Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) Tax Provisions (2023 - 2025)

Arcutis Biotherapeutics has reported Tax Provisions over the past 3 years, most recently at $499000.0 for Q4 2025.

  • Quarterly results put Tax Provisions at $499000.0 for Q4 2025, up 54.49% from a year ago — trailing twelve months through Dec 2025 was $1.2 million (up 85.47% YoY), and the annual figure for FY2025 was $1.2 million, up 85.47%.
  • Tax Provisions for Q4 2025 was $499000.0 at Arcutis Biotherapeutics, up from $80000.0 in the prior quarter.
  • Over the last five years, Tax Provisions for ARQT hit a ceiling of $3.0 million in Q3 2023 and a floor of $12000.0 in Q4 2023.
  • Median Tax Provisions over the past 3 years was $323500.0 (2024), compared with a mean of $610250.0.
  • Biggest five-year swings in Tax Provisions: surged 2591.67% in 2024 and later dropped 13.89% in 2025.
  • Arcutis Biotherapeutics' Tax Provisions stood at $12000.0 in 2023, then surged by 2591.67% to $323000.0 in 2024, then surged by 54.49% to $499000.0 in 2025.
  • The last three reported values for Tax Provisions were $499000.0 (Q4 2025), $80000.0 (Q3 2025), and $342000.0 (Q2 2025) per Business Quant data.